The development of a Middle Market business is a natural extension of MUFG’s successful global Healthcare Banking practice which underwrote $33.5 billion in loan transactions in 2018, the second-highest total in the industry. MUFG’s current Middle Market Healthcare clients have more than $2.5 billion in commitments, and come from sectors including healthcare services, medical technology and pharmaceuticals.
The bank defines the healthcare middle market as companies with $2 billion or less in annual revenue.
MUFG’s Middle Market Healthcare group is led by Beth Everett, a managing director with more than 25 years of experience. She joined the bank’s Healthcare Banking group in 2012 and reports to Allen Fisher, global head of Healthcare.
“As a global leader in healthcare finance, MUFG is well-positioned to provide the products and services most important to middle market companies — whether it’s transaction banking, leveraged finance or asset-based lending,” said Everett. “Further, with our presence in more than 50 countries, we can offer clients growth opportunities that we see via our broader healthcare practice, as well as access to the world’s capital markets.”
MUFG’s Middle Market Healthcare team also works closely with financial sponsors, an effort led by Steven Killilea, a Managing Director in MUFG’s Healthcare Banking group.
“Our relationships with private equity firms that invest in healthcare is particularly important,” said Killilea. “We provide these clients with financing to support domestic and international acquisitions, recapitalizations, working capital and additional liquidity.”
To underscore his point, Killilea pointed to 2018’s middle market M&A volume of $428 billion, of which 53% was private equity-related, with healthcare accounting for 13% of the total.
When it comes right down to it, the vendor finance segment of the equipment leasing and finance business has become stale, boring and bereft of innovative products and services. Six years ago I wrote an article predicting the future of... read more
Monitor’s Top 25 Vendor Players broke the $40 billion mark in new originations this year, but while most saw positive growth, the overall percentage increase slipped slightly from 6.4% in 2017 to 6.1% in 2018. The top eight companies from... read more